Precision Trial Drawer, a Computational Tool to Assist Planning of Genomics-Driven Trials in Oncology.

Melloni, Giorgio E M; Guida, Alessandro; Curigliano, Giuseppe; Botteri, Edoardo; Esposito, Angela; Kamal, Maude; Le Tourneau, Christoph; Riva, Laura; Magi, Alberto; de Maria, Ruggero; Pelicci, Piergiuseppe; Mazzarella, Luca

Melloni, Giorgio E M; Guida, Alessandro; Curigliano, Giuseppe; Botteri, Edoardo; Esposito, Angela; Kamal, Maude; Le Tourneau, Christoph; Riva, Laura; Magi, Alberto; de Maria, Ruggero; Pelicci, Piergiuseppe; Mazzarella, Luca.

Afiliación

Melloni GEM; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli
Guida A; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli
Curigliano G; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli
Botteri E; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli
Esposito A; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli
Kamal M; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli
Le Tourneau C; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli
Riva L; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli
Magi A; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli
de Maria R; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli
Pelicci P; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli
Mazzarella L; Giorgio E.M. Melloni, Harvard Medical School, Boston, MA; Giorgio E.M. Melloni and Laura Riva, Italian Institute of Technology; Alessandro Guida, Giuseppe Curigliano, Angela Esposito, Piergiuseppe Pelicci, and Luca Mazzarella, European Institute of Oncology; Giuseppe Curigliano and Piergiuseppe Peli

JCO Precis Oncol ; 2: 1-16, 2018 Nov.

Article en En | MEDLINE | ID: mdl-35135136

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: JCO Precis Oncol Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google